首页 正文

Mycobacterium tuberculosis inhibitors: an updated patent review (2021-present)

{{output}}
Introduction: Tuberculosis (TB) remains a major global health issue, causing around 10 million new cases and 1.3 million deaths in 2022. The challenge is compounded by multidrug-resistant (MDR) and extensively drug-resistant (XDR... ...